United States Knee Reconstruction Market Outlook to 2033 - Primary Knee Replacement, Partial Knee Replacement and Revision Knee Replacement

The “United States Knee Reconstruction Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Knee Reconstruction market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Primary Knee Replacement, Partial Knee Replacement and Revision Knee Replacement

The United States Knee Reconstruction Market report provides key information and data on:

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2024 company share data for Knee Reconstruction Market.
Global corporate-level profiles of key companies operating within the United States Knee Reconstruction Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Knee Reconstruction is segmented as follows:

Primary Knee Replacement
Partial Knee Replacement
Revision Knee Replacement

Reasons to Buy

The United States Knee Reconstruction Market report helps you to develop:

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Knee Reconstruction Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Knee Reconstruction Market, United States

3.1 Knee Reconstruction Market, United States, Revenue ($m), 2018-2033
3.1.1 Partial Knee Replacement Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Primary Knee Replacement Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Knee Reconstruction Market, United States, Volume (Units), 2018-2033
3.2.1 Partial Knee Replacement Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Primary Knee Replacement Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Knee Reconstruction Market, United States, Average Price ($) , 2018-2033
3.4 Knee Reconstruction Market, United States, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in United States, Knee Reconstruction Market

4.1 Zimmer Biomet Holdings Inc
4.1.1 Company Overview
4.2 Stryker Corp
4.2.1 Company Overview
4.3 DePuy Synthes Inc
4.3.1 Company Overview
4.4 Smith & Nephew Plc
4.4.1 Company Overview
4.5 Waldemar Link GmbH & Co KG
4.5.1 Company Overview
4.6 Medacta International SA
4.6.1 Company Overview
4.7 MicroPort Scientific Corp
4.7.1 Company Overview
4.8 Enovis Corp
4.8.1 Company Overview
4.9 Corin Group Ltd
4.9.1 Company Overview
4.10 Amplitude SAS
4.10.1 Company Overview
4.11 B. Braun Melsungen AG
4.11.1 Company Overview
4.12 United Orthopedic Corp
4.12.1 Company Overview
4.13 Exactech Inc
4.13.1 Company Overview
4.14 Corentec Co Ltd
4.14.1 Company Overview
4.15 Baumer SA
4.15.1 Company Overview

5 Knee Reconstruction Market Pipeline Products

6 Financial Deals Landscape

6.1 Debt Offerings
6.1.1 Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032

7 Recent Developments

7.1 Corporate Communications
7.1.1 May 20, 2025: FDA clears Trax Surgical’s compression staple system for orthopaedic use
7.1.2 Jan 15, 2025: The University of Florida Appoints Waste Pro Vice President to Advisory Board
7.1.3 Dec 11, 2024: Paragon 28 Appoints Dave Demski to Board of Directors
7.1.4 Aug 08, 2024: Paragon 28 Appoints Chadi Chahine as Chief Financial Officer and Executive Vice-President of Supply Chain Operations, Reports Second Quarter 2024 Financial Results and Narrows 2024 Net Revenue Guidance
7.2 Financial Announcements
7.2.1 Apr 16, 2025: Assure Tech (Hangzhou) Receives CLIA Approval for FaStep Multi-Drug Urine Test Panel
7.2.2 Apr 15, 2025: Orthofix to Report First Quarter 2025 Financial Results
7.2.3 Jan 28, 2025: Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
7.2.4 Jan 13, 2025: Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024
7.2.5 Nov 12, 2024: Paragon 28 Reports Third Quarter 2024 Financial Results and Raises 2024 Net Revenue Guidance
7.2.6 Nov 07, 2024: Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets
7.2.7 Oct 10, 2024: Orthofix to Report Third Quarter 2024 Financial Results
7.2.8 Oct 09, 2024: Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
7.2.9 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results
7.2.10 Aug 08, 2024: Paragon 28 Appoints Chadi Chahine as Chief Financial Officer and Executive Vice-President of Supply Chain Operations, Reports Second Quarter 2024 Financial Results and Narrows 2024 Net Revenue Guidance
7.2.11 Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results
7.2.12 Jul 09, 2024: Orthofix to Report Second Quarter 2024 Financial Results
7.2.13 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024
7.3 Government and Public Interest
7.3.1 Mar 25, 2025: Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference
7.3.2 Mar 03, 2025: Orthofix to Participate in the 37th Annual Roth Conference
7.3.3 Feb 10, 2025: Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
7.3.4 Nov 18, 2024: Paragon 28 to Present at the 36th Annual Piper Sandler Healthcare Conference
7.3.5 Nov 12, 2024: Orthofix to Participate in Upcoming Investor Conferences
7.3.6 Oct 21, 2024: Orthofix to Participate in Stifel 2024 Healthcare Conference
7.4 Legal And Regulatory
7.4.1 Jun 13, 2025: FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer, Backed by Dana-Farber Research
7.4.2 Jun 04, 2025: Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
7.5 Other Significant Developments
7.5.1 Oct 04, 2024: Rapides Regional performs first wireless, handheld robotic knee replacement surgery in Louisiana
7.5.2 Jul 23, 2024: ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)
7.6 Product News
7.6.1 Jun 10, 2025: New Study Shows Outstanding Long-Term Outcomes for Zimmer Total Ankle Replacement Using Unique Lateral Approach
7.6.2 Dec 12, 2024: Researchers at Medical College of Wisconsin Advance Treatments for Hip, Knee Replacements
7.6.3 Nov 22, 2024: Geisinger, Medacta Announce First Shoulder Replacement with Lifetime Guarantee
7.6.4 Nov 17, 2024: Surprising Study Finds No Link Between Rheumatoid Arthritis and Transfusion Risk After Knee Replacement
7.7 Strategy And Business Planning
7.7.1 Jan 08, 2025: Moonlake Initiates Three New Clinical Trials and Further Expands the Portfolio of Indications for the Nanobody Sonelokimab

8 Appendix

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer

List of Tables

Table 1: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Knee Reconstruction Market, United States, Volume (Units), 2018-2033
Table 5: Partial Knee Replacement Market, United States, Volume (Units), 2018-2033
Table 6: Primary Knee Replacement Market, United States, Volume (Units), 2018-2033
Table 7: Knee Reconstruction Market, United States, Average Price ($), 2018-2033
Table 8: Knee Reconstruction Market, United States, Company Share by Revenue ($m), 2024
Table 9: Knee Reconstruction Market Pipeline Products
Table 10: Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032
Table 11: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

Figure 1: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Knee Reconstruction Market, United States, Volume (Units), 2018-2033
Figure 5: Partial Knee Replacement Market, United States, Volume (Units), 2018-2033
Figure 6: Primary Knee Replacement Market, United States, Volume (Units), 2018-2033
Figure 7: Knee Reconstruction Market, United States, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Amplitude SAS
B. Braun Melsungen AG
Baumer SA
Corentec Co Ltd
Corin Group Ltd
DePuy Synthes Inc
Enovis Corp
Exactech Inc

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4435EUR$4,995USD£3,847GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€8869EUR$9,990USD£7,694GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€13304EUR$14,985USD£11,541GBP

The United States Knee Reconstruction Market report provides key information and data on:

Scope

United States Knee Reconstruction is segmented as follows:

Reasons to Buy

The United States Knee Reconstruction Market report helps you to develop:

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

North America Knee Reconstruction Market Outlook to 2033 - Primary Knee Replacement, Partial Knee Replacement and Revision Knee Replacement

Knee Reconstruction Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

Knee Reconstruction Market by Technology (Computer Assisted Navigation, Conventional Manual, Patient Specific Instrumentation), End User (Ambulatory Surgical Centers, Hospitals), Product Type, Fixation - Global Forecast 2025-2030

Knee Reconstruction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Knee Reconstruction Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)